GeneDx Share Price

GeneDx Share Price

NASDAQ: WGS | Small Cap | Healthcare
$45.38
-$3.77 (-7.67%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

GeneDx Stock Performance

Open
$47.85
Prev. Close
$49.15
Circuit Range
N/A
Day Range
$45.23 - $48.80
Year Range
$32.33 - $170.36
Volume
45,962
Average Traded
$46.65

GeneDx Share Price Today

As of 21 November 2026, GeneDx Holdings Corp. Class A's share price is $45.38. The stock opened at $47.85, compared to its previous close of $49.15. During today's trading session, GeneDx Holdings Corp. Class A's share price traded between $45.23 and $48.80, with an average price of $47.02. Over the past 52 weeks, the stock has recorded a high of $170.36 and a low of $32.33. In terms of performance, GeneDx Holdings Corp. Class A's share price has declined by 12.52% over the last six months and is down 72.63% on a year-on-year basis.

GeneDx Share Price Chart

Line chart of the GeneDx price trend over the selected period. The price fell overall, ranging from 45.19 to 48.80, ending at 45.38.
$45.23$48.80
L
Show Current Price
H

GeneDx Stock Fundamentals & Key Indicators

Market Cap
$1.30B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.71
Revenue (TTM)
$427.54B
Return On Equity (TTM)
-45.49%
Profit Margin
-4.92%
Debt to Equity
0.60
Quarterly Earnings Growth YoY
30.22%

GeneDx Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$120.99$102.25$114.44$123.10
Net Profit-$17.67-$63.57-$17.74-$12.33
Net Profit Margin-14.60%-62.17%-15.50%-10.02%
Income ChangeN/A-259.76%72.09%30.50%

GeneDx Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$202.57$305.45$427.54
Net Profit-$175.77-$52.29-$21.02
Net Profit Margin-86.77%-17.12%-4.92%
Income ChangeN/A70.25%59.80%

GeneDx Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets255.42221.41236.42
Current Assets268.29197.97182.34
Total Assets523.71419.38418.76
Non Current Liabilities106.62119.32131.92
Current Liabilities108.9154.8258.82
Total Liabilities215.53174.13190.74
Shareholders' Equity308.18245.25228.02

GeneDx Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating33.28-28.5-180.15
Investing-61.52-30.13-43.73
Financing48.0344.16186.24

Corporate Actions

Split
Ex-date: 04 May 2023

About GeneDx

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

GeneDx Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$69.53
$45.26
-34.42%
Oct 2026
$73.61
$69.02
-4.87%
Sep 2026
$83.91
$72.56
-18.71%
Aug 2026
$65.72
$89.25
+37.22%
Jul 2026
$70.32
$65.04
-5.36%
Jun 2026
$51.69
$68.72
+32.47%
May 2026
$63.88
$51.88
-17.37%
Apr 2026
$65.91
$62.78
-2.34%
Mar 2026
$78.36
$64.28
-19.25%
Feb 2026
$96.73
$79.61
-17.24%
Jan 2026
$131.79
$96.19
-26.01%
Dec 2025
$161.47
$130.01
-21.60%

GeneDx Share Price FAQs